CellWell record HH-195912
Development of a multi-targeted sulfonyl-bridged bisselenadiazole derivative as a potent EGFR/PI3K/AKT/mTOR modulator in lung adenocarcinoma
Wesam Abd El-Fattah; Ahlem Guesmi; Naoufel Ben Hamadi; Abdelwahed R Sayed; Ahmed A M El-Reedy; Hani S Hafez; Reda F M Elshaarawy; Soha A Hassan
2026
In plain language
A novel selenium-containing compound reduced lung adenocarcinoma cell viability through apoptosis induction and global rewiring of oncogenic signaling pathways.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-195912
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.